The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Open accessAbstract
The cardiovascular system ensures the delivery of oxygen and nutrients to all cells, tissues, and organs. Under extended exposure to reduced oxygen levels, cells are able to survive through the transcriptional activation of a series of genes that participate in angiogenesis, glucose metabolism, and cell proliferation. The oxygen-sensitive transcriptional activator HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions. The HIF-1 pathway was found to be a master regulator of angiogenesis. Whether the process is physiological or pathological, HIF-1 seems to participate in vasculature formation by synergistic correlations with other proangiogenic factors such as VEGF (vascular endothelial growth factor), PlGF (placental growth factor), or angiopoietins. Considering the important contributions of HIF-1 in angiogenesis and vasculogenesis, it should be considered a promising target for treating ischaemic diseases or cancer. In this review, we discuss the roles of HIF-1 in both physiological/pathophysiological angiogenesis and potential strategies for clinical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of HIF-α gene structures and DNA binding. (a) HIF-1α and HIF-2α contain the following domains: a nuclear localisation domain (NLS), DNA binding and dimerisation domains (bHLH/PAS), oxygen-dependent degradation domain (ODDD), and cofactor interaction and transcriptional activity domains (N-TAD/C-TAD). HIF-3α lacks a C-TAD domain. NLS: nuclear localisation signal; bHLH: basic helix-loop-helix domain; PAS: Per-ARNT-Sim motif; ODDD: oxygen-dependent degradation domain; N-TAD: N-terminal transactivation domain; C-TAD: C-terminal transactivation domain. (b) Dimerisation of HIF-1α with HIF-1β under hypoxic conditions results in the formation of the HIF-1 transcription factor, which binds to hypoxia response elements (HREs) and activates the transcription of O2-dependent genes (according to [134]).](https://figures.cochat.ai/paper-figures/7f1eff6f4e4b425f9d8561e5e5c9be64/hypoxia-inducible-factor-1-in-physiological-and-pathophysiological-angiogenesis-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the normal developmental setting, HIF-1α plays a dominant role throughout vasculogenesis, whereas HIF-2α contributes primarily to vessel remodeling and maturation during the later stages of vasculogenesis (the HIF switch) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Characteristics of tumor vasculature include lack of stabilization by pericytes and smooth muscle cells and a lack of an arterial or venous phenotype that leads to leakage, poor blood flow and perfusion (Figure 3) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 2×
“Because the uterine environment is hypoxic it is thereby obvious that hypoxiamay be the primary stimulus of vessel formation [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 1×
“growth factors that activate their receptors [5, 6].”
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“Vessel formation occurs via only two basicmechanisms: vasculogenesis and angiogenesis [2].”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Research works printed but not linked: 11
- 1998, Journal of Cellular Biochemistry, 30-31, 168
- 2005, Science's STKE, 2005
- 1998, Gene Expression, 7, 205
- 1999, Cancer Research, 59, 3915
- 2003, Cancer Research, 63, 1138
- 1992, Obstetrics and Gynecology, 80, 283
- 2015, Tissue Engineering Part A, 21
- 1997, Tumour angiogenesis, 181
- 1998, Cancer Research, 58, 1408
- 2014, Journal of Physiology and Pharmacology, 65, 193
- 2000, Nature Medicine, 61, 49
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
“Angiogenesis also contributes to the progression of various malignant tumors such as melanoma, breast cancer (BC),(10) colorectal cancer (CRC),(11) non-small cell lung cancer (NSCLC),(12) and renal cell carcinoma (RCC).(13) The tumor is a biological tissue with rapid proliferation, vigorous metabolism, and tenacious v…”
BackgroundTong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
“Recent investigations demonstrated that Cu is closely correlated with the expression level of hypoxia-inducible factor 1α [152, 153], which stimulates angiogenesis, and neovascularization in turn induces the production of vascular endothelial growth factor [154].”
BackgroundHypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Teleanu, R. I., Chircov, C., Grumezescu, A. M., & Teleanu, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010084 · Cited by 503
“Thus, it is safe to assume that in normal oxygen levels within cells and tissues, HIF-1α is degraded, thus inhibiting the VEGF gene and protein expression and stopping the cascade of proangiogenic factors [60].”
BackgroundHypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Tirpe, A. A., Gulei, D., Ciortea, S. M., Crivii, C., & Berindan-Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246140 · Cited by 438
“HIF-1α translocate into the nucleus and binds its heterodimer counterpart, HIF-1β, with consecutive generation of active HIF-1 which is ready to bind to hypoxia-responsive elements (HREs) and regulate the gene expression of various targets [16].”
BackgroundPhysical Activity and Brain Health
Di Liegro, C. M., Schiera, G., Proia, P., & Di Liegro, I. (2019) · Genes · doi:10.3390/genes10090720 · Cited by 370
“Genes important for the adaptation of cells to hypoxic conditions and targets of HIFs are, for example, those encoding glucose transporters, glycolytic enzymes, and angiogenic growth factors [161,162].”
BackgroundThe roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Hypoxia-Inducible Factors and Cancer
Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0062-7 · Cited by 248
Schatz, F., Guzeloglu-Kayisli, O., Arlier, S., Kayisli, U. A., & Lockwood, C. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw004 · Cited by 243
Reactive Oxygen Species and Antioxidants in Wound Healing: Mechanisms and Therapeutic Potential
Ukaegbu, K., Allen, E., & Svoboda, K. K. H. (2025) · International Wound Journal · doi:10.1111/iwj.70330 · Cited by 184
The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism
Lv, X., Li, J., Zhang, C., Hu, T., Li, S., He, S., Yan, H., Tan, Y., Lei, M., Wen, M., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2016.11.003 · Cited by 209
“This ability of tumor cell involves a multistep process, termed the ‘angiogenic switch’, a phenomenon occurs when the balance of pro-angiogenic factors outweighs anti-angiogenic factors.46 HIF can induce the expression of a large number of pro-angiogenic factors, including vascular endothelial growth factor (VEGF), VE…”
BackgroundSilk Fibroin Biomaterials and Their Beneficial Role in Skin Wound Healing
Mazurek, Ł., Szudzik, M., Rybka, M., & Konop, M. (2022) · Biomolecules · doi:10.3390/biom12121852 · Cited by 179
“It results in active endothelial cell proliferation, increased wound capillary density, and blood flow restoration [36,42,43].”
BackgroundThe Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis
Bakleh, M. Z., & Zen, A. A. H. (2025) · Cells · doi:10.3390/cells14090673 · Cited by 204
“Genetic studies show evidence of severe structural abnormalities of blood vessels during placental development in mouse embryos deficient in either HIF-1 α or HIF-1 β [145].”
Hypoxia: The Cornerstone of Glioblastoma
Domènech, M., Hernández, A., Plaja, A., Martínez-Balibrea, E., & Balañà, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212608 · Cited by 173
“First, tumor cells gather around pre‐exist‐ ing vessels and proliferate after vascular regression occurs, enhancing tumor necrosis; fi‐ nally, the formation of a new vessel network is established [23].”
BackgroundReassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Elebiyo, T., Rotimi, D. E., Evbuomwan, I. O., Maimako, R. F., Iyobhebhe, M. E., Ojo, O. A., Oluba, O. M., & Adeyemı, O. S. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100620 · Cited by 201
Pulp Vascularization during Tooth Development, Regeneration, and Therapy
Rombouts, C., Giraud, T., Jeanneau, C., & About, I. (2017) · Journal of Dental Research · doi:10.1177/0022034516671688 · Cited by 159
Vascularization in tissue engineering: fundamentals and state-of-art
Yang, G., Mahadik, B. P., Choi, J. Y., & Fisher, J. P. (2019) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ab5637 · Cited by 182
Tumor Neovascularization and Developments in Therapeutics
Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., & Takayama, K. (2019) · Cancers · doi:10.3390/cancers11030316 · Cited by 161
“HIF-1α binds to the HRE of VEGFA, PDGF, and transforming growth factor-alpha, inducing their expression (Figure 1) [58].”
BackgroundANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
Ma, S., Lü, C., Yang, L.-Y., Wang, J.-J., Wang, B., Cai, H., Hao, J., Xu, X., Cai, Y., Zhang, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0851-y · Cited by 149
Dhiman, N., Kaur, K., & Jaitak, V. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115599 · Cited by 147
Yang, R., Li, Y., Wang, H., Qin, T., Yin, X., & Ma, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00071-6 · Cited by 154
Vallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 149
“Several molecular pathways are involved in pathophysiological angiogenesis (Zimna and Kurpisz, 2015).”
BackgroundThe Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
Cheng, Y., Li, S., Gao, L., Zhi, K., & Ren, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761379 · Cited by 137
Li, L., Mu, J., Zhang, Y., Zhang, C., Ma, T., Chen, L., Huang, T., Wu, J., Cao, J. X., Feng, S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02898 · Cited by 136
Vallée, A., & Lecarpentier, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072440 · Cited by 139
“Numerous pathways are involved in the different angiogenesis processes [47].”
BackgroundVascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
Geindreau, M., Ghiringhelli, F., & Bruchard, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094871 · Cited by 135
“Deficiency in HIF-1α or HIF-1β results in aberrant placental architecture composed of few blood vessels and an early embryogenic lethality in mice [19].”
BackgroundViscor, G., Torrella, J. R., Corral, L., Ricart, A., Javierre, C. F., Pagés, T., & Ventura, J. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00814 · Cited by 124
Copper in cancer: from limiting nutrient to therapeutic target
Tang, X., Yan, Z., Miao, Y., Ha, W., Li, Z., Yang, L., & Mi, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1209156 · Cited by 120
Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
Samec, M., Líšková, A., Koklesová, L., Meršaková, S., Strnádel, J., Kajo, K., Péč, M. J., Zhai, K., Šmejkal, K., Mirzaei, S., et al. (2021) · Cancers · doi:10.3390/cancers13010130 · Cited by 123
“HIF-1 represents a critical transcription factor that is closely related to the regulation of genes responsible for angiogenesis [110], metastasis [111], cell survival, proliferation [112], and apoptosis [113].”
BackgroundWang, W., Lu, Z., Wang, M., Liu, Z., Wu, B., Yang, C., He, H., & Gong, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998236 · Cited by 139
“Studies have confirmed that copper is closely related to the expression level of hypoxia-inducible factor 1a (HIF-1a) (62).”
BackgroundRegulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Camuzi, D., de Amorim, Í. S. S., Pinto, L. F. R., Trivilin, L. O., Mencalha, A. L., & Soares‐Lima, S. C. (2019) · Cells · doi:10.3390/cells8040300 · Cited by 111
“In tumors, when cell growth overcomes that of healthy tissues, a hypoxia microenvironment is created, and VEGF can be stimulated independently or directly by hypoxia-inducible factors [110,111].”
BackgroundRegulation of tumor angiogenesis by microRNAs: State of the art
Goradel, N. H., Mohammadi, N., Haghi‐Aminjan, H., Farhood, B., Negahdari, B., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27051 · Cited by 109
“Subsequently, HIF‐1α translocates into the nucleus and dimerizes with HIF‐1β. HIF‐1α/β dimer as a transcription factor activates target genes such as VEGF and increases angiogenesis (Zimna & Kurpisz, 2015).”
BackgroundProtein cargo in extracellular vesicles as the key mediator in the progression of cancer
Hánělová, K., Raudenská, M., Masařík, M., & Balvan, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01408-6 · Cited by 116
“HIF-1 works synergistically with other pro-angiogenic factors, namely VEGF, placental growth factor (PIGF), and angiopoietin 1/2 and upregulates their expression [147].”
BackgroundMelatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Goradel, N. H., Asghari, M. H., Moloudizargari, M., Negahdari, B., Haghi‐Aminjan, H., & Abdollahi, M. R. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.09.022 · Cited by 108
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Tilak, M., Holborn, J., New, L. A., Lalonde, J., & Jones, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041831 · Cited by 109
“Furthermore, the hypoxic environment of GBM triggers the “angiogenic switch” [132], wherein the production of HIF‐1α induces transcription of VEGF itself [133].”
BackgroundCurrent Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Mediratta, K., El‐Sahli, S., D’Costa, V. M., & Wang, L. (2020) · Cancers · doi:10.3390/cancers12123529 · Cited by 106
“However, the hypoxic conditions of the TME hijack this balance in favor of dysregulated angiogenesis [72,73].”
BackgroundPulido-Escribano, V., Torrecillas-Baena, B., Camacho-Cardeñosa, M., Dorado, G., Gálvez-Moreno, M. Á., & Casado‐Díaz, A. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i7.453 · Cited by 112
Gene therapy to enhance angiogenesis in chronic wounds
Shaabani, E., Sharifiaghdam, M., Majidi, R. F., Smedt, S. C. D., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.020 · Cited by 108
“The angiogenic process, at the molecular level, is regulated by hypoxia-inducible factor-1 (HIF-1),(82,83) which mediates the cellular response to hypoxia, and promotes pro-angiogenic gene transcription, thus stimulating neovascularization.(84,85) HIF-1 is a heterodimeric protein that consists of a highly regulated a-…”
Linking tumour angiogenesis and tumour immunity
Kabir, A. U., Subramanian, M., Kwon, Y., & Choi, K. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01211-z · Cited by 110
Oxygen Regulation in Development: Lessons from Embryogenesis towards Tissue Engineering
Fathollahipour, S., Patil, P. S., & Leipzig, N. D. (2018) · Cells Tissues Organs · doi:10.1159/000493162 · Cited by 101
The Molecular Adaptive Responses of Skeletal Muscle to High-Intensity Exercise/Training and Hypoxia
Li, J., Li, Y., ATAKAN, M. M., Kuang, J., Hu, Y., Bishop, D. J., & Yan, X. (2020) · Antioxidants · doi:10.3390/antiox9080656 · Cited by 110
“All of these findings offer evidence for the effects of HIF-1 on angiogenesis [88].”
BackgroundMolecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X., Qian, D. Z., & Dai, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 102
Zehra, M., Zubairi, W., Hasan, A., Butt, H., Ramzan, A., Azam, M., Mehmood, A., Falahati, M., Chaudhry, A. A., Rehman, I. U., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s248911 · Cited by 95
Hypoxia-Inducible Factor 1-Alpha (HIF-1α): An Essential Regulator in Cellular Metabolic Control
Basheeruddin, M., & Qausain, S. (2024) · Cureus · doi:10.7759/cureus.63852 · Cited by 95
“Comprehending the pro-inflammatory T-cell response and anti-tumor immunity, along with the role of metabolic regulation through HIF-1 α in chronic inflammation, cancer, and ischemic diseases, is crucial for developing therapeutic approaches [9].”
BackgroundA model of guided cell self-organization for rapid and spontaneous formation of functional vessels
Andrique, L., Recher, G., Alessandri, K., Pujol, N., Feyeux, M., Bon, P., Cognet, L., Nassoy, P., & Bikfalvi, A. (2019) · Science Advances · doi:10.1126/sciadv.aau6562 · Cited by 96
Guo, X., & Chen, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01668 · Cited by 93
“Neovascularization is generally connected to hypoxia in both physiological and pathological states (26, 27).”
BackgroundNovel Drugs with High Efficacy against Tumor Angiogenesis
Qi, S., Deng, S., Lian, Z., & Yu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136934 · Cited by 99
“The HIF-1α pathway has been shown to be a master regulator of vasculature formation by upregulating these factors, such as VEGF [72].”
BackgroundThe Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 93
“) signaling, and through this vascular structure [180].”
Rossi, J., Céballos, P., & Lu, Z. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0379-3 · Cited by 90
“This includes cycling hypoxia with spatial and temporal fluctuations in oxygen levels that are correlated to neo-vascularization, chemoresistance, and tumor metastasis [18, 19].”
BackgroundDurymanov, M. O., Kamaletdinova, T., Lehmann, S. E., & Reineke, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.013 · Cited by 88
“As in the case of normal tissue growth, pathological neovascularization is a hypoxia-driven process [7,8].”
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Ciepła, J., & Smolarczyk, R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01501-1 · Cited by 87
“It may also enhance expression of other pro-angiogenic factors such as placental growth factor (PlGF) and FGF. Sufficient oxygenation of tumor tissue would stop the cascade [159]0.4.4.”
BackgroundInfluentialWang, M., Yan, J., Cao, X., Hua, P., & Li, Z. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113775 · Cited by 86
Vascularization of self-assembled peptide scaffolds for spinal cord injury repair
Tran, K. A., Partyka, P. P., Jin, Y., Bouyer, J., Fischer, I., & Galie, P. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.12.033 · Cited by 82
Görtz, G.-E., Horstmann, M., Aniol, B., Reyes, B. D., Fandrey, J., Eckstein, A. K., & Berchner‐Pfannschmidt, U. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1279 · Cited by 82
Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction–Mediated Cell-Cell Interaction
Kikuchi‐Taura, A., Okinaka, Y., Takeuchi, Y., Ogawa, Y., Maeda, M., Kataoka, Y., Yasui, T., Kimura, T., Gul, S., Claussen, C., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.028072 · Cited by 81
A novel view of ferritin in cancer
Pandya, B., & Connor, J. R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188917 · Cited by 89
Research Progress on Tumor‐Associated Macrophages and Inflammation in Cervical Cancer
Liu, Y., Li, L., Li, Y., & Zhao, X. (2020) · BioMed Research International · doi:10.1155/2020/6842963 · Cited by 83
“HIF triggers other inflammatory mediators and proteases to participate in tumorigenesis and plays a major role in cell transformation, promotion, survival, proliferation, invasion, angiogenesis, and metastasis [53, 54].”
BackgroundVEGF in Diabetic Retinopathy and Age-Related Macular Degeneration
Callan, A., Heckman, J., Tah, G., Lopez, S., Valdez, L., & Tsin, A. T. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114992 · Cited by 79
“The transcription of VEGF is a process that is controlled by the presence or absence of oxygen its effects on hypoxia-inducible factors (HIF) [19,20].”
Yu, H., Li, Y., Pan, Y., Wang, H., Wang, W., Ren, X., Yuan, H., Lv, Z., Zuo, Y., Liu, Z., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01847-w · Cited by 78
“As a key upstream transcription factor, HIF-1α plays important roles in bone tissue engineering via VEGF [38, 39] and stromal cell-derived factor 1 (SDF-1) generation to upregulate the VEGF-induced vascularization and SDF-1 induced progenitor cells recruitment [40, 41].”
BackgroundMolecular Mechanisms of Antiproliferative Effects of Natural Chalcones
Michalková, R., Mirossay, L., Gazdova, M., Kello, M., & Mojžíš, J. (2021) · Cancers · doi:10.3390/cancers13112730 · Cited by 77
“Hypoxia is a key stimulus that induces angiogenesis via the activation of hypoxiainducible transcription factor (HIF-1) with subsequent activation of other proangiogenic factors [198].”
BackgroundPro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer
Herrera-Vargas, A. K., García-Rodríguez, E., Olea‐Flores, M., Catalán, M. A. M., Flores‐Alfaro, E., & Navarro‐Tito, N. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.10.006 · Cited by 79
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
Leone, P., Buonavoglia, A., Fasano, R., Solimando, A. G., Re, V. D., Cicco, S., Vacca, A., & Racanelli, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122030 · Cited by 78
“Under hypoxic condition, HIF-1α degradation is inhibited, resulting in an increase of HIF-1α levels and the promotion of angiogenesis [37].”
BackgroundZhu, D., Wang, Y., Thomas, M., McLaughlin, K., Oguljahan, B., Henderson, J., Yang, Q., Chen, Y. E., & Liu, D. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.010 · Cited by 76
Antiangiogenic Effect of Alkaloids
Alasvand, M., Assadollahi, V., Ambra, R., Hedayati, E., Kooti, W., & Peluso, I. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9475908 · Cited by 75
“Hypoxia leads to HIF-1α stabilization, a subunit of the heterodimeric transcription factor HIF-1, and increased VEGF production [12, 13].”
BackgroundChen, L., Oh, D., Ryu, M., Yeh, K., Yeo, W., Carlesi, R. M., Cheng, R., Kim, J.-S., Orlando, M., & Kang, Y. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.176 · Cited by 75
Shi, Z., Hu, C., Zheng, X., Sun, C., & Li, Q. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00519-1 · Cited by 75
“Hypoxia upregulates the pro-angiogenic VEGF [154], placental growth factor (PlGF) and fibroblast growth factor (FGF) [155].”
BackgroundMirabelli, M., Misiti, R., Sicilia, L., Brunetti, F. S., CHIEFARI, E. D., Brunetti, A., & FOTI, D. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189802 · Cited by 75
“…genes include GLUT1, which facilitates basal glucose uptake independent of insulin [44], along with leptin [45], adiponectin [35,46], the major angiogenic factor vascular endothelial growth factor (VEGF) [47], and several enzymes involved in glucose metabolism such as phospho-fructokinase [48].”
BackgroundHypoxia-inducible factor 1 in autoimmune diseases
Deng, W., Feng, X., Li, X., Wang, D., & Sun, L. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.04.001 · Cited by 75
Park, S., Mattè, A., Jung, Y., Ryu, J., Anand, W., Han, E.-Y., Liu, M., Carbone, C., Melisi, D., Nagasawa, T., et al. (2020) · Blood · doi:10.1182/blood.2019002227 · Cited by 72
Moeinabadi-Bidgoli, K., Babajani, A., Yazdanpanah, G., Farhadihosseinabadi, B., Jamshidi, E., Bahrami, S., & Niknejad, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112026 · Cited by 70
Mottaghi, S., & Abbaszadeh, H. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1931364 · Cited by 70
“HIF-1 is known as a primary regulator of VEGF during hypoxic conditions (102).”
BackgroundShoily, S. S., Ahsan, T., Fatema, K., & Sajib, A. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-86801-2 · Cited by 70
From Biomarkers to the Molecular Mechanism of Preeclampsia—A Comprehensive Literature Review
Rybak-Krzyszkowska, M., Staniczek, J., Kondracka, A., Bogusławska, J., Kwiatkowski, S., Góra, T., Strus, M., & Górczewski, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713252 · Cited by 69
Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
Lim, D., Do, Y., Kwon, B. S., Chang, W., Lee, M.-S., Kim, J., & Cho, J. G. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.6.060 · Cited by 77
“response element (HRE) to regulate the expression of hypoxiarelated molecues such as VEGF and EPO (55, 56), which allow tumor cells to adapt to a hostile microenvironment.”
BackgroundLazzara, F., Trotta, M. C., Platania, C. B. M., D’Amico, M., Petrillo, F., Galdiero, M., Gesualdo, C., Rossi, S., Drago, F., & Bucolo, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01063 · Cited by 70
“Besides VEGFA, HIF-1a can also induce the placental growth factor (PlGF) (Zimna and Kurpisz, 2015; Charnock-Jones, 2016; Mitsui et al., 2018), an emerging target in retinal neovascular diseases (Kwon and Jee, 2018; Lee et al., 2018; Saddala et al., 2018; Lazzara et al., 2019; Van Bergen et al.,…”
BackgroundParra‐Izquierdo, I., Castaños‐Mollor, I., López, J., Gómez, C., Román, J. A. S., Crespo, M. S., & García‐Rodríguez, C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.014 · Cited by 96
Li, H., Wang, H., Pan, J., Li, J., Zhang, K., Duan, W., Liang, H., Chen, K., Geng, D., Shi, Q., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c06906 · Cited by 67
Miao, A.-F., Liang, J.-X., Yao, L., Han, J.-L., & Zhou, L.-J. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1915801 · Cited by 68
“Meanwhile, vascular endothelial growth factor, which played a central role in angiogenesis, is also transcriptionally regulated by HIF [29].”
BackgroundRole of puerarin in pathological cardiac remodeling: A review
Lv, J., Shi, S., Zhang, B., Xu, X., Zheng, H., Li, Y., Cui, X., Wu, H., & Song, Q. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106152 · Cited by 67
Zhang, F., Lü, S., He, J., Jin, H., Wang, F., Wu, L., Shao, J., Chen, A., & Zheng, S. (2017) · Theranostics · doi:10.7150/thno.22237 · Cited by 66
“We investigated the underlying molecular mechanisms focusing on HIF-1α because this molecule plays a pivotal role in both physiological and pathological angiogenesis [27].”
BackgroundNanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
Arezumand, R., Alibakhshi, A., Ranjbari, J., Ramazani, A., & Muyldermans, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01746 · Cited by 72
“These new vessels are induced by various stimulators such as hypoxia, vessel damage, or angiogenesis growth factors that act as environmental triggers (37).”
BackgroundThe HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Ramakrishna, W., Kumari, A., Rahman, N., & Mandave, P. C. (2020) · Rice Science · doi:10.1016/j.rsci.2020.11.004 · Cited by 64
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
Yang, Y., Li, N., Wang, T., & Di, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910827 · Cited by 64
“Hypoxia can promote angiogenesis by increasing the expression and secretion of VEGF [87].”
BackgroundSorolla, M. A., Hidalgo, I. A., Sorolla, A., Montal, R., Pallisé, O., Salud, A., & Parisi, E. (2021) · Cancers · doi:10.3390/cancers13205037 · Cited by 64
“Vascular endothelial growth factor (VEGF) is of great relevance and is the primary factor initiating the angiogenic cascade, promoting the extravasation of plasma proteins and forming a primitive scaffold for migrating endothelial cells [84].”
BackgroundMolecular and Circulating Biomarkers in Patients with Glioblastoma
Senhaji, N., Houssaini, A. S., Lamrabet, S., Louati, S., & Bennis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137474 · Cited by 62
“This contributes to the development of GBM alongside the VEGF receptor, given its large involvement in the angiogenic signaling pathway, and the master regulator of glioblastoma expansion and aggressivity [163], otherwise known as hypoxiainduced angiogenesis [164].”
BackgroundKumar, P., Satyam, A., Cigognini, D., Pandit, A. S., & Zeugolis, D. I. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2283 · Cited by 62
Unraveling the molecular mechanisms between inflammation and tumor angiogenesis.
Zhou, W., Yang, L., Nie, L., & Lin, H. (2021) · PubMed · Cited by 62
Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
Wu, H., Norton, V., Cui, K., Zhu, B., Bhattacharjee, S., Lu, Y. W., Wang, B., Shan, D., Wong, S., Dong, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841928 · Cited by 72
Jiang, L., Li, Y., He, Y., Wei, D., Yan, L., & Wen, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.711207 · Cited by 60
Fleischer, J. R., Schmitt, A. M., Haas, G., Xu, X., Zeisberg, E. M., Bohnenberger, H., Küffer, S., Teuwen, L.-A. M. N., Karras, P. J., Beißbarth, T., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01713-1 · Cited by 63
“Murine haploinsuficiency of ADAMTS1, a desintegrin and metallopeptidase with described angiogenic-related functions causes thoracic aortic aneurysms and dissections similar to Marfan syndrome [64], while silencing of the poorly investigated small hydrophobic membrane-associated protein EMP1 inhibis cancer cell prolife…”
BackgroundInfluentialExploring Dysregulated Signaling Pathways in Cancer
Nisar, S., Hashem, S., Macha, M. A., Yadav, S. K., Muralitharan, S., Therachiyil, L., Sageena, G., Al‐Naemi, H. A., Haris, M., & Bhat, A. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115095937 · Cited by 60
Clinical Genetics of Prolidase Deficiency: An Updated Review
Spodenkiewicz, M., Spodenkiewicz, M., Cleary, M., Massier, M., Fitsialos, G., Cottin, V., Jouret, G., Poirsier, C., Doco‐Fenzy, M., & Lèbre, A.-S. (2020) · Biology · doi:10.3390/biology9050108 · Cited by 59
Dai, C., Webster, K. A., Bhatt, A. R., Tian, H., Su, G., & Li, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094809 · Cited by 59
“HIFs are central to both physiological and pathological angiogenesis in many organs [23].”
BackgroundSatyam, A., Kumar, P., Cigognini, D., Pandit, A. S., & Zeugolis, D. I. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.08.008 · Cited by 58
Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis
Gong, Y., Yu, Z., Wang, Y., Xiong, Y., Zhou, Y., Liao, C., Li, Y., Luo, Y., Bai, Y. Z., Chen, B., et al. (2019) · Pain Research and Management · doi:10.1155/2019/4705247 · Cited by 58
“Angiogenesis is the core premise of synovitis continuous reaction and mainly results in the hypoxia state of tissues [20].”
BackgroundChen, H., Ma, D., Yue, F., Qi, Y., Dou, M., Cui, L., & Xing, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210729123137 · Cited by 57
“Vessel maturation occurs in the final stages of angiogenesis, and primarily involves the recruitment of supporting cells, such as pericytes and smooth muscle cells (SMCs), to promote vessel maturation and stabilization [53, 56].”
An Introduction to Fundamentals of Cancer Biology
Sriharikrishnaa, S., Suresh, P. S., & Kabekkodu, S. P. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-031-31852-8_11 · Cited by 59
Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases
Moreno, C., Santos, R. M., Burns, R., & Zhang, W. C. (2020) · Cancers · doi:10.3390/cancers12113237 · Cited by 62
“For instance, lipopolysaccharide-stimulated interleukin 1 beta (IL-1β) release in macrophages promotes inflammation via increased succinate levels, resulting in PHD-mediated HIF-1α accumulation [55] or SDH-catalyzed ROS production [56].”
BackgroundInfluentialHeat stress affects dairy cow health status through blood oxygen availability
Zeng, J. S., Cai, J., Wang, D., Liu, H., Sun, H., & Liu, J. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00915-3 · Cited by 57
“Hypoxia transactivates target genes such as VEGF [52] and directly enhances angiogenesis by promoting VEGF expression [53].”
Background
Metadata
- Authors
- Zimna, A., & Kurpisz, M.
- Affiliations
- Institute of Human Genetics (PL)
- Corresponding author
- Kurpisz, Maciej
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4471260
- OpenAlex
- W1597158509
- Cited by
- 604
- References
- 138
- Citations by year
- 2026: 40 · 2025: 66 · 2024: 88 · 2023: 78 · 2022: 67 · 2021: 79 · 2020: 64 · 2019: 45 · 2018: 22 · 2017: 28 · 2016: 23 · 2015: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Centre, Poland (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- National Centre for Research and Development (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, angiogenesis, hypoxia, vascular endothelial growth factor, placental growth factor, angiopoietins, vasculogenesis, ischemic diseases, cancer, oxygen sensing, transcriptional regulation
- MeSH terms
- Placenta Growth Factor, Hypoxia, Humans, Neovascularization, Pathologic, Pregnancy Proteins, Transcriptional Activation, Cell Hypoxia, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.